Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Medically supervised programs help those who want a healthier lifestyle than ever before
The company has a patient assistance program for people who qualify
continued 5.5% additional loss in tirzepatide continuation group SURMOUNT-4: Weight maintenance trial confirming sustained benefits over extended treatment [1] November 2023: FDA Approval for Obesity Zepbound (tirzepatide) approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with weight-related comorbidities
Welcome to place an order
US$ 28.82
US$ 27.60
US$ 21.83
US$ 22.11
